1.

Quantification of disparities in the distribution of lifestyle and metabolic risk factors, prevalence of non-communicable diseases and related mortality: the Belgian Health Intervi...

1.

Predicting COVID-19 progression in hospitalized patients in Belgium from a multi-state model

1.

Additional file 1 of The future burden of type 2 diabetes in Belgium: a microsimulation model ...

2.

Additional file 1 of The future burden of type 2 diabetes in Belgium: a microsimulation model ...

3.

Additional file 1 of The future burden of type 2 diabetes in Belgium: a microsimulation model ...

1.

The future burden of type 2 diabetes in Belgium: a microsimulation model ...

2.

The future burden of type 2 diabetes in Belgium: a microsimulation model ...

3.

The future burden of type 2 diabetes in Belgium: a microsimulation model ...

1.

The future burden of type 2 diabetes in Belgium: a microsimulation model

2.

The future burden of type 2 diabetes in Belgium: a microsimulation model

3.

The future burden of type 2 diabetes in Belgium: a microsimulation model

4.

The future burden of type 2 diabetes in Belgium: a microsimulation model

5.

The future burden of type 2 diabetes in Belgium: a microsimulation model

1.

Additional file 1 of Comparing self-reported health interview survey and pharmacy billing data in determining the prevalence of diabetes, hypertension, and hypercholesterolemia in...

2.

Additional file 1 of Comparing self-reported health interview survey and pharmacy billing data in determining the prevalence of diabetes, hypertension, and hypercholesterolemia in...

3.

Additional file 1 of Comparing self-reported health interview survey and pharmacy billing data in determining the prevalence of diabetes, hypertension, and hypercholesterolemia in...

1.

Comparing self-reported health interview survey and pharmacy billing data in determining the prevalence of diabetes, hypertension, and hypercholesterolemia in Belgium ...

2.

Comparing self-reported health interview survey and pharmacy billing data in determining the prevalence of diabetes, hypertension, and hypercholesterolemia in Belgium ...

3.

Comparing self-reported health interview survey and pharmacy billing data in determining the prevalence of diabetes, hypertension, and hypercholesterolemia in Belgium ...

1.

Comparing self-reported health interview survey and pharmacy billing data in determining the prevalence of diabetes, hypertension, and hypercholesterolemia in Belgium

1.

Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium

2.

Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium

3.

Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium

1.

Insights into the association of ACEIs/ARBs use and COVID-19 prognosis : a multistate modelling study of nationwide hospital surveillance data from Belgium